Summary by Futu AI
JUN SHENG TAI PHARMACEUTICAL-B (02511.HK) FILED ITS LATEST SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON MARCH 5, 2024, REPORTING CHANGES IN THE COMPANY'S SHARE CAPITAL AS OF FEBRUARY 29, 2024. The report shows that the company's regulated/registered capital and issued shares did not decrease during the reporting period, and the total regulated/registered share capital remained at $100,000, with a face value of $0.0001 per share, and the total number of shares was 1,000,000,000 shares. In addition, the report confirms that the securities issued by the company this month have been formally authorized by the Board and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited. Dr. Liu Liping, Executive Director and Chief Executive Officer, is the submitter of this report.